{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:37:29Z","timestamp":1764085049989},"reference-count":69,"publisher":"Baishideng Publishing Group Inc.","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4254\/wjh.v9.i19.833","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:50:38Z","timestamp":1499215838000},"page":"833","source":"Crossref","is-referenced-by-count":11,"title":["Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease"],"prefix":"10.4254","volume":"9","author":[{"given":"Marco","family":"Ladino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i2.213"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.031"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.548"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50073"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.06.011"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2011.5.2.117"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.10.005"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.81"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302183280703"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000333772"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.327"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.06.003"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108153250702"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04320416"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.018"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i27.6214"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.12860\/JNP.2013.36"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250529"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.75"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000377"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208339"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel004"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.01.008"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.065565"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5301\/IJAO.2012.9448"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12413"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100790"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-187"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.455"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000355803"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27664"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010030"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1505074"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03091.x"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13620"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001618"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13518"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.01.025"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182848de2"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2012.01633.x"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00868.x"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2008.00990.x"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006070736"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07940716"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002113"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26892"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2004.00252.x"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Ruh\u0131 \u00c7, S\u00fcleymanlar \u0130, Ko\u00e7ak H, Yilmaz VT, \u00c7olak D, D\u0131n\u00e7kan A, G\u00fcrkan A, Ersoy F, Yakupo\u011flu G, S\u00fcleymanlar G. The impact of hepatitis C virus infection on long-term outcome in renal transplant patients. Turk J Gastroenterol 2011;22:165-170.","DOI":"10.4318\/tjg.2011.0236"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010060668"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant 2001;16:1545-1549.","DOI":"10.1093\/ndt\/16.8.1545"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12835"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.565"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.11.050"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592-599.","DOI":"10.7326\/0003-4819-133-8-200010170-00009"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01040.x"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Delgado-Borrego A, Casson D, Schoenfeld D, Somsouk M, Terella A, Jordan SH, Bhan A, Baid S, Cosimi AB, Pascual M. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004;77:703-710.","DOI":"10.1097\/01.TP.0000114283.04840.3A"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02843.x"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-013-0370-3"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.194"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Cruzado JM, Carrera M, Torras J, Griny\u00f3 JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001;1:171-178.","DOI":"10.1034\/j.1600-6143.2001.10212.x"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Roth D, Cirocco R, Zucker K, Ruiz P, Viciana A, Burke G, Carreno M, Esquenazi V, Miller J. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995;59:1676-1682.","DOI":"10.1097\/00007890-199506270-00006"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13102"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.004"},{"key":"ref64","unstructured":"Sabucedo A, Antoine M, Jorge D, Andreu A, Pedraza F, Hernandez M, Jeffers L, Ladino M. Sofosbuvir use in patients with Hepatitis C virus infection and severe chronic kidney disease [Abstract]. J Am Soc Nephrol 2015;26:663A."},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.078"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00349-9"},{"key":"ref67","unstructured":"Vierling JM. RUBY-I Study, cohort 2: ombitasvir\/paritaprevir\/ritonavir dasabuvir \u00b1 RBV for HCV genotype 1 with renal impairment. AASLD 2016;Abs. 886 Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcv-trials.com\/showStudy.asp?Study=144\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hcv-trials.com\/showStudy.asp?Study=144<\/ext-link>."},{"key":"ref68","unstructured":"Gane E. RUBY-II Study: ombitasvir\/paritaprevir\/ritonavir \u00b1 dasabuvir for HCV genotype 1a or 4 with severe renal impairment. AASLD 2016;Abs. 935 Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcv-trials.com\/showStudy.asp?Study=139\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hcv-trials.com\/showStudy.asp?Study=139<\/ext-link>."},{"key":"ref69","unstructured":"Gane E. EXPEDITION-IV Study: glecaprevir\/pibrentasvir in patients with renal impairment. AASLD 2016;Abs Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcv-trials.com\/showStudy.asp?Study=132\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hcv-trials.com\/showStudy.asp?Study=132<\/ext-link>."}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v9\/i19\/833.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T09:35:18Z","timestamp":1569663318000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v9\/i19\/833.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":69,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v9.i19.833","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}